Savran Technologies

About:

Savran Technologies offers non-invasive diagnostics based on capture and analysis of rare cells.

Top Investors: TBD Angels, Walnut Venture Associates

Description:

Savran Technologies offers non-invasive diagnostics based on the capture and analysis of rare cells. Initial applications in oncology, immuno-oncology, and pre-natal. The company was established in 2018 and operates in Cambridge, Massachusetts, United States.

Total Funding Amount:

$6.19M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2018-01-01

Contact Email:

kathryn(AT)savrantech.com

Founders:

Cagri Savran

Number of Employees:

1-10

Last Funding Date:

2024-08-30

IPO Status:

Private

Industries: